Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
13.3%
% of HART's 84 holdings also in HRTS
25.6%
% of HRTS's 39 holdings also in HART
Overlap by Weight
Sector Drift (HART minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.8% | 6.4% | 4.8% |
 |
NOVO NORDISK A/S-B | 4.6% | 3.6% | 3.6% |
 |
ASTRAZENECA PLC | 4.9% | 3.1% | 3.1% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 3.1% | 2.8% |
 |
MEDTRONIC PLC | 2.6% | 3.0% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to HRTS
|
UNITEDHEALTH GROUP INC | 5.7% |
|
APPLE INC | 5.6% |
|
JOHNSON & JOHNSON | 5.4% |
|
PFIZER INC | 5.3% |
|
ABBOTT LABORATORIES | 5.1% |
|
ALPHABET INC. CLASS A | 4.8% |
 |
NOVARTIS AG | 4.0% |
|
ELEVANCE HEALTH INC | 3.1% |
 |
SANOFI-AVENTIS | 3.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% |
HART Underweight Relative to HRTS
|
VERTEX PHARMACEUTICALS INC | -5.7% |
|
AMGEN INC | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
|
ASCENDIS PHARMA A/S | -3.1% |
|
DEXCOM INC | -2.7% |
|
CYTOKINETICS INC | -2.7% |
|
MIRUM PHARMACEUTICALS, INC. | -2.6% |